Last Week in Weed: December 30, 2025-January 6, 2026
The new year brings with it groundbreaking news in cannabis policy, business, and culture. As we wade into 2026, Cannabis & Tech Today is catching you up on the latest
The new year brings with it groundbreaking news in cannabis policy, business, and culture. As we wade into 2026, Cannabis & Tech Today is catching you up on the latest
Welcome to the latest edition of “Last week in Weed,” catching you up on the latest breaking news and industry developments in the world of cannabis.
The recent Forbes report on Medicare’s movement toward covering hemp-derived products, arriving at the exact moment Congress is advancing a sweeping federal ban on most hemp cannabinoids, perfectly captures the
Welcome to the latest edition of “Last week in Weed,” catching you up on the latest breaking news and industry developments in the world of cannabis.
In a landmark executive order signed Thursday, President Donald Trump directed federal agencies to reclassify marijuana from Schedule I to Schedule III under the Controlled Substances Act. This policy shift
According to a report published on December 11, 2025, by The Washington Post, President Donald Trump is considering an executive order that would direct federal agencies to reclassify marijuana from
Catch up on the latest cannabis industry news, from ‘scromiting’ health warnings to federal hemp restrictions, veterans’ access issues, and the biggest stock movements in early December 2025
Explore how THC-V—a rare, fast-emerging cannabinoid—could reshape the medical cannabis market. Learn about its potential roles in appetite control, metabolic health, neurological support, industry impact, and the challenges still facing research and regulation.
Catch up on the biggest cannabis news from the past week: Tilray’s reverse stock split rocks the market, holiday sales surge, and Massachusetts faces a ballot battle over adult-use cannabis.
Your weekly cannabis update covering key headlines, industry trends, international news, and the top performing and lagging cannabis stocks.
Welcome to the latest edition of “Last week in Weed,” catching you up on the latest breaking news and industry developments in the world of cannabis.
Exposing Pharma Strategies to Dominate the US Cannabis Market — uncover how Big Pharma plans to control the cannabis industry.
Visit AMPED at MJBizCon Booth NI5523 to explore how integrated collaboration can propel your cultivation venture.
As hemp and THC laws clash, confusion grows. This article breaks down the legal, cultural, and scientific divide reshaping the cannabis industry.
Catch up on this week’s top cannabis news, from Sorting Robotics’ new automation service to market movements, hemp bans, industry trends, stock movements and international news
From new Florida dispensaries and exclusive genetics drops to major legal battles and cannabis stock swings, get a complete recap of the week’s biggest cannabis industry and culture news.
This week in cannabis: Ohio halts hemp-derived THC sales, Germany restricts online prescriptions, Michigan rolls out a 24% cannabis tax, and Tilray, Aurora, Canopy, and Cronos show mixed stock movements amid regulatory uncertainty.
Late September cannabis news roundup: market moves, regulatory updates, new product launches, and seasonal campaigns shaping the industry this fall.
Metrc and BioTrack’s new partnership could reshape cannabis compliance, raising concerns over vendor lock-in, market control, and the future of state tracking systems.
Cannabis industry roundup: FinCEN banking data, Texas THC regulations, Charlotte’s infused “happy sauce,” UK CBD review, new retail merchandising program, Trump’s India tariffs hitting pre-rolls, and the latest on cannabis stocks.
